None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged 19 to 70 years 2) Isolated-impaired glucose tolerance (plasma glucose levels from 140 to 199 mg/dl two hours after a 75 g oral glucose consumption during an oral glucose tolerance test) 3) Voluntary agreement to participate in the clinical trials and provision of informed consent
Exclusion criteria
Exclusion criteria: 1) Fasting plasma glucose level 3 fold of normal range or serum creatinine > 2.0 mg/dl 16) Female subjects of childbearing potential who are not willing to use appropriate contraception (except for surgery for female infertility) 17) Pregnant, planning to become pregnant, or breast-feeding 18) Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-hour postprandial plasma glucose;Incremental area under the curve | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting plasma glucose;Postprandial plasma glucose (30, 60, and 90 min);Fasting insulin;HOMA-IR, QUICKI;Lipid profile (total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol);Adiponectin;Leptine;Short chain fatty acid;Gut microbiome | — |
Countries
Korea, Republic of
Contacts
Jeonbuk National University Hospital